We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
21/3/2021 12:28 | Hi, I'm new to this. These shares were inherited and this is all foreign to me!! I am in the UK. HELP! I didn't switch to ADR's a few years ago and stuck with ordinary shares. I have 500 of them. Does this mean that it equates to around 41 ADR's? So with the buyout, it looks like I'm going to receive around $600. :( I 'think' the shares are actually worth $1020?? So should I find a broker and sell before the buyout??? Thanks for any advice!! | kes411 | |
03/2/2021 13:08 | Yep - its been a long journey with many a twist along the way! Still got a few hundred - but this won't be life changing! | future financier | |
03/2/2021 12:49 | Yes but only hundreds of ADS. Nothing compared to the number I used to hold. | cfb2 | |
03/2/2021 12:47 | Well, its just been taken out for $220..anyone still in from the uk listing days... | miti 1000 | |
13/3/2019 20:30 | i guess i was right afterall...but got stopped out due to VOG | johncasey | |
05/11/2018 21:26 | Funny how things pan out. I was in the middle of a house purchase and financial reorganisation so didn't buy a single share on this... I knew the Co read this BB... hope you all did well!! (Chuckle!) | sojourno | |
01/11/2018 09:50 | harry - it is 12 uk shares to 1 adr | future financier | |
31/10/2018 18:05 | What is the corelation between shares in the UK company and the quoted Nasdaq ADR price? | harry hasta | |
02/10/2018 04:47 | Contact the company secretary of the UK part of GWP. | wengerb | |
02/10/2018 04:47 | Contact the company secretary of the UK part of GWP. | wengerb | |
27/9/2018 17:44 | I still have the original GWP share certificate. I seem to be getting nowhere trying to transfer to ADR. Does anyone know where I can go for some assistance? Help would be greatly appreciated | gwright1 | |
08/10/2017 11:50 | [...] Merrill Lynch Ups Motif Bio Stake Following Iclaprim Results (ALLISS) By Alliance | Fri, 6th October 2017 - 14:19 LONDON (Alliance News) - Merrill Lynch International has raised its stake Motif Bio PLC under a transaction on Wednesday and now holds 5.038% interest in the pharmaceutical company. The purchase came on the same day Motif Bio reported positive results from its phase III clinical study of flagship antibiotic Iclaprim. Iclaprim met its primary endpoint in the phase III trial in patients with acute bacterial skin and skin structure infections, which was non-inferiority whilst compared to the standard of care vancomycin. Earlier today, Motif Bio released new pre-clinical data showing positive results regarding the use of Iclaprim. In an in vivo model mimicking the pathophysiology observed in cystic fibrosis patients, rats were dosed with either 80 or 60 milligrams of Iclaprim, 50 mg of Vancomycin, and a placebo. The Iclaprim rats showed a 100% survival rate, 33 out of 33, while Vancomycin showed 92% survival rate and the placebo 48%. Merrill Lynch had a holding that was below the notable threshold prior to the purchase. Motif Bio shares were up 6% on Friday at 46.11 pence. By Joshua Warner; joshuawarner@allianc Read more: A step ahead of ImmuPharma is Motif Bio, which has successfully completed not one, but two phase III clinical trials and is preparing to submit its antibiotic, iclaprim, for regulatory sign-off. While the shares are up 23 per cent this week at around 43p, analysts think it could be worth double that figure. Amphion Innovations, the investment group, owns just over 14 per cent of Motif. Its chief executive thinks market hasn’t quite grasped how valuable this shareholding is. He might be right as Amphion’s market capitalisation is some way short of the value of its Motif investment | cool druid | |
04/1/2017 10:51 | Is there a new thread? | kdr246 | |
09/12/2016 08:33 | Thanks nodding, my shares are in crest so gwp communications would have went to the broker. I guess I need to get self trade to speak to citi to get it sorted out. Anyone know if I need a wii-ben before getting the adrs? | 1leigh | |
09/12/2016 01:03 | Re: Insys Their CBD product is discussed on pages 4 and 5. Nowhere can I see the word epilepsy. However, the reference to pediatric schizophrenia is new, I think. GW have had a completed phase II trial on schizophrenia for some time but we have not had any guidance on whether they will take it further. | ih_406638 | |
08/12/2016 23:59 | You should have had a letter from GW describing your options. In mine it says Citibank will charge a conversion fee of $0.05 per ADR after the delisting date. You will be charged SDRT as well. Certificated ord shares are not quoted by anyone, so they are not fixed at 716p | ih_406638 | |
08/12/2016 23:47 | future financer - thanks for that, I'm more relaxed knowing that something can be salvaged. Thought the funds were gone. GWP was in the bottom drawer for probably more than ten years so far and only the share price not moving for 4 days alerted me to something not being quite right! Will selftrade actually issue paper certificates, rather than continue to hold in CREST? A question, is the price of the shares I hold fixed at 716? If so changing to ADR sooner rather than later is probably advisable? And I remember when I held Elan (also many years ago), that to hold ADR stocks, does a tax form need to be completed? Thanks again all! | 1leigh | |
08/12/2016 12:55 | You still own GWP shares - and you will at some point receive a share certificate from GWP. If you are holding on for a massive payday when GWP is sold then nothing is lost - any purchaser will just have to buy your shares from you directly (so keep the certificate safe!). Similarly GWP will pay any dividends to you. All that is lost is that you cannot trade your shares. If you want to trade them then you will need to contact the Depository bank - Citibank - who will charge you a fairly nominal fee for buying your shares and then issuing you with the requisite number of ADRs. You will then be left with a rump of up to 11 shares (assuming your GWP shareholding is not an exact multiple of 12) which you can deal with as in the first paragraph. A pain - but nothing too major lost - just chase up Selftrade for the timing on the issue of the certificate. | future financier | |
08/12/2016 12:32 | Hi, been a gwp shareholder for years, and logged into my self trade account today only to read the messages about the delisting. Feeling a bit of a prat for not keeping on top of things but also annoyed that the default action of do nothing has left me with shares I can't use. Is there hope? Can I still convert then or is it several grand down the swanny? Anyone else in the same position, though if you post here you're probably on the ball. | 1leigh | |
07/12/2016 10:34 | In the new GWPH thread, if you click on the blank where the charts should be it will take you to the ADVFN 'adjustable' chart. Problem with the code or < img > thingy that wraps the URL? Is the title a deliberate attempt to fly under the radar? | neilrr | |
07/12/2016 10:16 | Wenger. It does now but without the graphics. Interesting that we have what appears to be 'today's' price on this page. | 123prezzie |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions